半乳糖凝集素3在静脉血管畸形中表达的研究进展  

Advances in the expression of Galectin-3 in venous malformations

作　　者：张德馨 林俊杰 乔军波 Zhang Dexin;Lin Junjie;Qiao Junbo(Department of Hemangioma Surgery,the Third Affiliated Hospital of Zhengzhou University,Zhengzhou 450003,China)

机构地区：[1]郑州大学第三附属医院血管瘤外科,450003

出　　处：《中华实验外科杂志》2020年第12期2365-2367,共3页Chinese Journal of Experimental Surgery

基　　金：河南省科技智库调研项目(HNKJZK-2020-15B)。

摘　　要：静脉血管畸形(VMs)对人类健康的危害日益加重,病理机制复杂,其中重症静脉血管畸形综合征尚无根治办法。现有研究证据表明半乳糖凝集素3(Gal-3)与血管生成、静脉血栓形成密切相关,Gal-3在VMs组织中高表达,提示Gal-3可能参与VMs的发生与发展,并促进VMs局部血管内凝血(LIC)。本文拟对Gal-3与VMs的关系作一综述。Venous malformations(VMs)are increasingly harmful to human health with a complex pathological mechanism.Among them,there is no radical cure for severe venous vascular malformation syndrome.Existing research evidences showed that Galectin-3(Gal-3)is closely related to angiogenesis and venous thrombosis.High expression of Gal-3 in VMs tissues suggests Gal-3 may be involved in the occurrence and development of VMs.It also promoted the local intravascular coagulation(LIC)of VMs.In this paper,we will reveiw the relationship between Gal-3 and VMs.

关 键 词：静脉血管畸形 半乳糖凝集素3 血管生成 血栓 

分 类 号：R737.25[医药卫生—肿瘤]